Could a drug combo make HPV head and neck cancer more vulnerable?
Disease control
Recruiting now
This study tests whether giving a chemotherapy drug (5-azacytidine) and an immunotherapy drug (nivolumab) together, before surgery, can boost the immune system's attack on HPV-related head and neck cancer. About 50 people with resectable oropharynx cancer will receive one or both…
Phase: PHASE2 • Sponsor: Barbara Burtness • Aim: Disease control
Last updated May 04, 2026 04:29 UTC